A summary of item and method of national chronic obstructive pulmonary disease surveillance in China
Fang, L.W.; Bao, H.L.; Wang, B.H.; Feng, Y.J.; Cong, S.; Wang, N.; Fan, J.; Wang, L.H.
Zhonghua Liu Xing Bing Xue Za Zhi 39(5): 546-550
2018
ISSN/ISBN: 0254-6450 PMID: 29860792 Document Number: 694938
COPD是一类严重影响我国居民健康和生活质量的慢性呼吸系统疾病。2014年中国开展COPD监测项目，旨在掌握≥40岁居民COPD患病情况以及相关影响因素的流行和变化趋势。本文将对"中国居民COPD监测项目"内容和方法进行简要介绍。.
Document emailed within 1 workday
Related Documents
Laitinen, L.A.; Koskela, K. 1999: Chronic bronchitis and chronic obstructive pulmonary disease: Finnish National Guidelines for Prevention and Treatment 1998-2007 Respiratory Medicine 93(5): 297-332Zhang, R.; Zhang, A.; He, Q.; Lu, B. 2002: Microsomal epoxide hydrolase gene polymorphism and susceptibility to chronic obstructive pulmonary disease in Han nationality of North China Zhonghua Nei Ke Za Zhi 41(1): 11-14
Chuaychoo, B.; Maranetra, N.; Naruman, C.; Dejsomritrutai, W.; Lertakyamanee, J.; Chierkul, N.; Nana, A.; Thamlikitkul, W.; Suthamsmai, T.; Saengkaew, S.; Sreelum, W.; Aksornin, M.; Dechapol, A.; Sathet, W. 2003: The most cost-effective screening method for chronic obstructive pulmonary disease among the Bangkok elderly Journal of the Medical Association of Thailand 86(12): 1140-1148
Xu, Y.J.; Zhang, Z.X.; Duan, S.F. 1991: Pulmonary artery compliance and its relation with pulmonary hemodynamics in patients with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 30(3): 138-140; 187
Wu, X-Hua.; Chen, M-Gang.; Zheng, J. 2005: Surveillance of schistosomiasis in five provinces of China which have reached the national criteria for elimination of the disease Acta Tropica 96(2-3): 276-281
Lewczuk, J.; Piszko, P.; Jagas, J.; Wrabec, K. 2005: Impact of 30 day therapy with doxazosin--alpha1 adrenergic blocker on pulmonary hemodynamics in patients with secondary pulmonary hypertension due to chronic obstructive pulmonary disease Polski Merkuriusz Lekarski: Organ Polskiego Towarzystwa Lekarskiego 18(105): 279-281
Rahimi-Rad, M.Hossein.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Rahimi-Rad, M.H.; Rahimi, P.; Rahimi, B.; Gholamnaghad, M. 2014: Serum CA-125 level in patients with chronic obstructive pulmonary disease with and without pulmonary hypertension Pneumologia 63(3): 164-166
Sarac, R.; Cikes, I.; Butković, D.; Dimov-Butković, D. 1995: Doppler echocardiography in the evaluation of pulmonary hypertension in chronic obstructive pulmonary disease Lijecnicki Vjesnik 117(1-2): 9-15
Cousineau, G.; Leveillé, P.; Lemire, P. 1983: Radiologic aspects of pulmonary edema in chronic obstructive pulmonary disease L'Union Medicale du Canada 112(1): 45-48
Incorvaia, C.; Russo, A.; Foresi, A.; Berra, D.; Elia, R.; Passalacqua, G.; Riario-Sforza, G.G.; Ridolo, E. 2014: Effects of pulmonary rehabilitation on lung function in chronic obstructive pulmonary disease: the FIRST study European Journal of Physical and Rehabilitation Medicine 50(4): 419-426
Deepak, T.H.; Mohapatra, P.R.; Janmeja, A.K.; Sood, P.; Gupta, M. 2014: Outcome of pulmonary rehabilitation in patients after acute exacerbation of chronic obstructive pulmonary disease Indian Journal of Chest Diseases and Allied Sciences 56(1): 7-12
Kasibowska-Kuźniar, K.; Jankowska, R.; Kuźniar, T. 2007: Quality of life outcomes of pulmonary rehabilitation in patients with chronic obstructive pulmonary disease (COPD) Wiadomosci Lekarskie 60(3-4): 158-161
Kirisawa, T. 1979: Studies on chronic obstructive pulmonary disease by selective alveolo-bronchography (SAB). Pulmonary emphysema lesions Nihon Kyobu Shikkan Gakkai Zasshi 17(4): 212-221
Nici, L.; Lareau, S.; ZuWallack, R. 2010: Pulmonary rehabilitation in the treatment of chronic obstructive pulmonary disease American Family Physician 82(6): 655-660
Ouksel, H.; Pison, C. 2004: Pulmonary rehabilitation in patients with chronic obstructive pulmonary disease La Revue du Praticien 54(13): 1432-1435
Vogelmeier, C.F.; Criner, G.J.; Martinez, F.J.; Anzueto, A.; Barnes, P.J.; Bourbeau, J.; Celli, B.R.; Chen, R.; Decramer, M.; Fabbri, L.M.; Frith, P.; Halpin, D.M.G.; López Varela, M.Victorina.; Nishimura, M.; Roche, N.; Rodriguez-Roisin, R.; Sin, D.D.; Singh, D.; Stockley, R.; Vestbo, Jørgen.; Wedzicha, J.A.; Agustí, A. 2017: Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary American journal of respiratory and critical care medicine 195(5): 557-582
Wan, P.; Zhong, X.-n.; He, Z.-y.; Zhang, J.-q.; Liu, G.-n.; Lao, Q.-f. 2009: The changes and significance of interleukin-16 and CXC chemokine receptor 3 expression in pulmonary artery of smokers with chronic obstructive pulmonary disease Zhonghua Nei Ke Za Zhi 48(10): 841-845
Dotsenko, E.K.; Goncharova, V.A.; Kuzubova, N.A.; Kamenova, M.Iu.; Egorova, N.V. 2008: The role of expired air moisture condensate in assessment of pulmonary inflammation in patients with chronic obstructive pulmonary disease Terapevticheskii Arkhiv 80(3): 10-14
Lampert, E.; Tuo, N.; Frans, A.; Lonsdorfer, J. 1991: Disappearance of molsidomine effects on pulmonary circulation of patients with chronic obstructive pulmonary disease after a three week treatment Pathologie-Biologie 39(1): 29-33